2022
DOI: 10.1371/journal.pone.0254972
|View full text |Cite
|
Sign up to set email alerts
|

Cytokines, chemokines and growth factors profile in human aqueous humor in idiopathic uveitis

Abstract: To investigate which cytokines, chemokines and growth factors are involved in the immunopathogenesis of idiopathic uveitis, and whether cytokine profiles are associated with. Serum and aqueous humor (AH) samples of 75 patients with idiopathic uveitis were analyzed by multiplex immunoassay. Infectious controls consisted of 16 patients with ocular toxoplasmosis all confirmed by intraocular fluid analyses. Noninfectious controls consisted of 7 patients with Behçet disease related uveitis and 15 patients with sarc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
30
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(33 citation statements)
references
References 62 publications
1
30
0
Order By: Relevance
“…A better understanding of ocular inflammation pathways has led to the emergence of biological therapies for the treatment of NIU [ 3 , 23 ] that aim to overcome the 30% failure rate obtained under classical immunosuppressive treatment [ 24 ]. Different cytokines such as TNFα, IL-6, IL-17, or IL-23 play a key role in NIU inflammatory process [ 25 ], therefore becoming very attractive as potential therapeutic targets. Bearing this in mind, randomized prospective studies have been developed in the last years to evaluate the treatment efficacy of biological drugs in NIU [ 6 , 7 , 26 ].…”
Section: Biologics In Uveitis Treatmentmentioning
confidence: 99%
See 1 more Smart Citation
“…A better understanding of ocular inflammation pathways has led to the emergence of biological therapies for the treatment of NIU [ 3 , 23 ] that aim to overcome the 30% failure rate obtained under classical immunosuppressive treatment [ 24 ]. Different cytokines such as TNFα, IL-6, IL-17, or IL-23 play a key role in NIU inflammatory process [ 25 ], therefore becoming very attractive as potential therapeutic targets. Bearing this in mind, randomized prospective studies have been developed in the last years to evaluate the treatment efficacy of biological drugs in NIU [ 6 , 7 , 26 ].…”
Section: Biologics In Uveitis Treatmentmentioning
confidence: 99%
“…The presence of inflammation can alter the biodistribution coefficients at the tissue level. In fact, patients with uveitis experience an increase in vascular permeability due to the release of inflammatory mediators, such as TNFα, IL-6, IL-8, IL-17, or IL-23 [ 25 , 111 , 112 ]. This increase in vascular permeability has an impact on the integrity of the ocular barriers, which may play an important role in the penetration of high molecular weight drugs such as mAb in tissues with limited access like the eye [ 113 ].…”
Section: Implications Of Ocular Drug Pkmentioning
confidence: 99%
“…Aqueous humor is the most commonly used intraocular fluid for testing ( 5 9 ). With the development of precision medicine techniques, intraocular fluid testing has been widely used in the treatment of infectious eye diseases such as acute retinal necrosis, ocular toxoplasmosis, various types of uveitis, and other infectious eye diseases, which provides an important basis for clinicians to make accurate judgments and provide targeted treatment ( 10 – 12 ). Although there have been studies on intraocular fluid testing in patients with PSS and OAG ( 13 – 15 ), most have been limited to the correlation between intraocular fluid composition and the disease itself, and there have been no studies evaluating risk factors associated with OAG secondary to PSS.…”
Section: Introductionmentioning
confidence: 99%
“…Recurrent anterior uveitis of unknown etiology (or idiopathic uveitis) is the most common form of uveitis [ 2 , 3 ]. This nosological form is registered in 36% of cases [ 4 ]. One of the most serious vision-threatening consequences of this condition is secondary glaucoma, which has an incidence of 5% to 24%.…”
Section: Introductionmentioning
confidence: 99%
“…Experts note that we know little about the immune mechanisms involved in uveitis and, particularly, in idiopathic form [ 4 , 23 ]. Considering the complex pathogenetic mechanism of uveitis, it is important to study the interaction of the immune and vascular systems, as well as prevention of irreversible morphological complications.…”
Section: Introductionmentioning
confidence: 99%